Criticizing Modified Ferriman-Gallwey Scoring System in the Evaluation of Hirsutism in 1034 Turkish Women

    January 2013 in “ Türkiye klinikleri tıp bilimleri dergisi ”
    Nurhan Döner, Tuğba Rezan Ekmekçi
    Image of study
    TLDR The study suggests using a score of 11 on the mFG scale to diagnose hirsutism in Turkish women, with adjustments for age, skin type, and family history.
    In 2013, a study involving 1034 Turkish women evaluated the effectiveness of the modified Ferriman-Gallwey (mFG) scoring system in diagnosing hirsutism. The average mFG score was 3.26±3.81, with higher scores observed in younger, dark-skinned women, and those with a family history of hirsutism, menstrual irregularity, and acne vulgaris. The 95th and 97.5th percentile mFG score values for all participants were 11.00 and 14.00 respectively, which decreased when excluding those with menstrual irregularities and acne vulgaris. The study concluded that an mFG score of 11 should be used as a cutoff for diagnosing hirsutism in Turkish women, but this value should be adjusted based on factors such as age, skin type, and family history.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 25 results

      community AA and Hirsutism but T levels are normal

      in Female  8 upvotes 3 years ago
      27-year-old female experiences aggressive hair thinning and hirsutism despite normal testosterone levels. Spironolactone and 2% minoxidil were ineffective; high DHEA sulfate levels may be the cause.

      community Finasteride 5mg & Spironolactone 100mg

      in Female  2 upvotes 3 weeks ago
      A 20-year-old female is using finasteride 5mg and spironolactone 100mg for severe hirsutism and is experiencing minor side effects like water weight loss and irregular periods. She is concerned about potential future side effects and hair regrowth on her scalp.

      community No, Finasteride as a treatment for MPB was not an "accident"

      in Research/Science  105 upvotes 3 years ago
      Finasteride was intentionally developed to treat BPH and later approved for male pattern baldness (MPB) due to its 5AR inhibition effects. The delay in MPB approval was due to concerns about off-label use for female hirsutism and the prioritization of treating a more debilitating condition.

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  118 upvotes 3 months ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

      community Does low HGH leading to hairloss?

      in Research/Science  12 upvotes 10 months ago
      The user experiencing diffuse hair loss is using various treatments including RU58841, finasteride, minoxidil with tretinoin, anti-hair loss shampoo, and microneedling, and is considering adding peptides TB500, BPC157, and GHK-Cu. They have low growth hormone levels and are questioning its impact on hair loss, while another user suggests androgenic alopecia and androgens are likely the main cause of hair loss.

    Related Research

    1 / 1 results